How long a patient with thalassemia can live cannot be generalized and needs to be analyzed according to the specific condition. Patients with thalassemia minor can survive with the disease for a long time and will not affect their life expectancy; for thalassemia intermedia, patients need long-term blood transfusion, so their life expectancy will be affected; for thalassemia major, it is difficult for patients to survive. Thalassemia is a familial hereditary hemolytic disease that usually develops in infancy, manifesting as hepatosplenomegaly, anemia and even heart failure. Depending on the severity of the disease, it can be classified as thalassemia minor, intermediate and major. In most patients with thalassemia minor, the disease is in a quiescent phase and therefore does not affect survival time. Patients with intermediate thalassemia may survive into middle adulthood due to the need for prolonged blood transfusion therapy during growth. Patients with thalassemia major usually do not survive from birth, and if they do, it is for a very short period of time. Aggressive implementation of standardized treatment is recommended for thalassemia in order to maximize the life expectancy of patients.